“…Therefore, lncRNAs can be used as potential biomarkers and therapeutic targets in cancers by interacting with proteins (Chandra Gupta and Nandan Tripathi, 2017). For example, Peng et al and her groups (Peng et al, 2021a;Zhou L. Q. et al, 2021;Peng et al, 2021b;Zhou L. et al, 2021;Tian et al, 2021;Peng et al, 2022) designed a series of state-of-the-art lncRNA-protein interaction prediction methods and significantly improved biomarker identification for various diseases. In addition, lncRNA SNHG14, BCRT1, DSCAM-AS1, MaTAR24, and HOTAIR have been validated to densely link to breast cancer (Niknafs et al, 2016;Dong et al, 2018;Chang et al, 2020;Liang et al, 2020;Yang et al, 2022;Xue et al, 2016).…”